6 April 2020 - On 24 March 2020, new restrictions came into effect limiting the health practitioners who could initiate therapy with hydroxychloroquine.
These were introduced following reports of increased off-label prescribing of medicines containing hydroxychloroquine, which had the potential to create a shortage of the product in Australia.
From 3 April 2020, dental board practitioners who are registered specialists in oral medicine have been added to the list of specialist health practitioners who are permitted to initiate treatment with hydroxychloroquine.